pegylated interferon for the treatment of polycythemia vera and essential thrombocythemia
Published 2 years ago • 1.6K plays • Length 3:09Download video MP4
Download video MP3
Similar videos
-
3:14
interim results of pegylated interferon alpha-2a for polycythemia vera and essential thrombocythemia
-
1:59
mpd-rc 112 trial of pegylated interferon alpha-2a for polycythemia vera & essential thrombocythemia
-
4:30
update on the use of interferon-alfa for polycythemia vera
-
1:32
qol for patients with polycythemia vera or essential thrombocythemia
-
1:43
updates from a phase ii study of bomedemstat for the treatment of essential thrombocythemia
-
3:06
the unmet needs of essential thrombocythemia and polycythemia vera patients
-
10:56
identifying and communicating your polycythemia vera (pv) symptoms
-
6:01
common signs and symptoms of polycythemia vera
-
5:34
understanding how polycythemia vera (pv) may change over time
-
1:26
agents of interest being explored in essential thrombocythemia and polycythemia vera
-
1:27
the use of interferons in the treatment of mpns
-
6:49
the role of interferon in polycythemia vera & perspectives on the management of low-risk patients
-
4:10
the management of polycythemia vera with cytoreductive drug therapy
-
2:25
interferons in the treatment of mpns: clinical trials in 2021
-
3:10
promising trials in polycythemia vera
-
2:06
clinical updates on the use of ropeginterferon for polycythemia vera
-
1:29
ropeginterferon alfa-2b for polycythemia vera: impacts and considerations
-
2:14
risk-adapted treatment of et & pv
-
6:38
novel approaches for mpns
-
2:46
an update on emerging therapies for the treatment of polycythemia vera
-
3:00
ropeginterferon alpha-2b as an effective treatment against pv
-
3:16
the importance of early intervention in young patients with mpns & the role of interferon therapy